Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
PDS Biotechnology Corporation (NASDAQ: PDSB) closed the day trading at $1.27 down -5.22% from the previous closing price of $1.34. In other words, the price has decreased by -$5.22 from its previous closing price. On the day, 1.13 million shares were traded.
Ratios:
For a better understanding of PDSB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.84 and its Current Ratio is at 2.84. In the meantime, Its Debt-to-Equity ratio is 1.12 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on November 01, 2022, initiated with a Buy rating and assigned the stock a target price of $10.
On June 28, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $25.
H.C. Wainwright Upgraded its Neutral to Buy on November 10, 2020, while the target price for the stock was maintained at $6.
Stock Price History:
Over the past 52 weeks, PDSB has reached a high of $6.68, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is -20.73%, while the 200-Day Moving Average is calculated to be -53.95%.
Shares Statistics:
A total of 36.82M shares are outstanding, with a floating share count of 36.02M. Insiders hold about 3.70% of the company’s shares, while institutions hold 11.35% stake in the company.
